ImmunityBio (IBRX) Property, Plant & Equipment (Net) Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PP&E (Net) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | -14.40% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3.41% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | -9.89% |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 13.10% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 10.71% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -0.31% |
| 10 | ImmunityBio | 7.72 Bn | 7.34 Bn | 43.97 Mn | -9.89% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.89% |
| Dec 31, 2025 | -7.35% |
| Sep 30, 2025 | -0.22% |
| Jun 30, 2025 | 3.65% |
| Mar 31, 2025 | 8.74% |
| Dec 31, 2024 | 18.27% |
| Sep 30, 2024 | 25.85% |
| Jun 30, 2024 | 16.83% |
| Mar 31, 2024 | 21.07% |
| Dec 31, 2023 | 26.28% |
| Sep 30, 2023 | 39.61% |
| Jun 30, 2023 | 37.23% |
| Mar 31, 2023 | 38.10% |
| Dec 31, 2022 | 33.41% |
| Sep 30, 2022 | 28.03% |
| Jun 30, 2022 | 22.43% |
| Mar 31, 2022 | 15.71% |
| Dec 31, 2021 | 2.53% |
| Sep 30, 2021 | -3.30% |
| Jun 30, 2021 | 4.41% |
| Mar 31, 2021 | 1.73% |
| Dec 31, 2020 | -1.85% |
| Sep 30, 2020 | -9.14% |
| Jun 30, 2020 | -0.90% |
| Mar 31, 2020 | 37.42% |
| Dec 31, 2019 | 47.36% |
| Sep 30, 2019 | 55.68% |
| Jun 30, 2019 | 89.88% |
| Mar 31, 2019 | 111.73% |
| Dec 31, 2018 | 140.56% |
| Sep 30, 2018 | 279.48% |
| Jun 30, 2018 | 205.61% |
| Dec 31, 2017 | 613.76% |